Nifty
Sensex
:
:
11767.75
40145.50
-162.60 (-1.36%)
-540.00 (-1.33%)

Pharmaceuticals & Drugs

Rating :
72/99  (View)

BSE: 524280 | NSE: KOPRAN

117.70
-2.30 (-1.92%)
26-Oct-2020 | 4:03PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  120.00
  •  123.95
  •  114.50
  •  120.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  727519
  •  856.29
  •  130.95
  •  15.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 507.14
  • 16.34
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 590.67
  • N/A
  • 2.49

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.78%
  • 4.08%
  • 42.43%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 9.71%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.45
  • 3.94
  • 4.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.97
  • 9.09
  • 9.96

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.59
  • 14.42
  • 0.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.84
  • 10.39
  • 8.07

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.69
  • 1.80
  • 1.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.80
  • 7.15
  • 6.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
121
84
44%
87
100
-12%
100
105
-5%
88
92
-5%
Expenses
101
77
32%
76
88
-14%
88
90
-2%
77
82
-6%
EBITDA
20
8
166%
11
12
-3%
12
16
-23%
11
10
6%
EBIDTM
17%
9%
13%
12%
12%
15%
12%
11%
Other Income
4
2
42%
0
4
-96%
1
2
-21%
1
0
414%
Interest
2
2
-11%
2
2
-9%
3
2
22%
2
3
-29%
Depreciation
3
2
10%
2
2
8%
2
2
11%
2
2
13%
PBT
19
6
241%
6
12
-44%
9
13
-36%
8
5
42%
Tax
5
1
252%
2
4
-57%
2
2
-10%
2
1
83%
PAT
14
4
237%
5
8
-37%
6
11
-42%
6
4
32%
PATM
12%
5%
6%
8%
6%
10%
6%
5%
EPS
3.29
0.98
236%
1.11
1.77
-37%
1.46
2.51
-42%
1.31
0.99
32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
396
360
358
313
310
296
326
303
250
199
192
Net Sales Growth
4%
0%
14%
1%
5%
-9%
8%
21%
26%
3%
 
Cost Of Goods Sold
232
193
191
172
165
167
194
172
142
117
114
Gross Profit
165
167
167
141
145
129
131
131
108
82
78
GP Margin
42%
46%
47%
45%
47%
44%
40%
43%
43%
41%
41%
Total Expenditure
342
313
312
284
274
266
294
260
217
178
174
Power & Fuel Cost
-
18
17
15
14
14
13
12
11
9
9
% Of Sales
-
5%
5%
5%
4%
5%
4%
4%
4%
4%
5%
Employee Cost
-
37
37
32
31
28
29
23
21
18
18
% Of Sales
-
10%
10%
10%
10%
9%
9%
8%
8%
9%
9%
Manufacturing Exp.
-
30
32
31
32
28
26
22
18
16
16
% Of Sales
-
8%
9%
10%
10%
9%
8%
7%
7%
8%
8%
General & Admin Exp.
-
21
19
19
17
16
15
14
11
10
9
% Of Sales
-
6%
5%
6%
5%
5%
5%
5%
5%
5%
5%
Selling & Distn. Exp.
-
9
9
10
8
9
8
9
7
6
5
% Of Sales
-
3%
3%
3%
3%
3%
3%
3%
3%
3%
2%
Miscellaneous Exp.
-
5
7
5
6
4
9
8
7
3
5
% Of Sales
-
1%
2%
2%
2%
1%
3%
2%
3%
1%
2%
EBITDA
54
47
45
29
36
30
31
43
34
21
18
EBITDA Margin
14%
13%
13%
9%
12%
10%
10%
14%
13%
11%
9%
Other Income
7
1
4
11
11
2
7
2
2
6
6
Interest
9
9
9
9
14
13
13
14
12
10
9
Depreciation
10
10
9
9
8
8
10
13
12
12
12
PBT
42
29
32
23
25
12
15
17
11
5
4
Tax
11
7
8
2
5
0
0
0
0
0
0
Tax Rate
26%
26%
24%
10%
20%
0%
0%
0%
0%
0%
-6%
PAT
31
21
24
20
20
11
-39
17
11
5
5
PAT before Minority Interest
31
21
24
20
20
11
-39
17
11
5
5
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
8%
6%
7%
7%
6%
4%
-12%
6%
4%
3%
2%
PAT Growth
15%
-12%
17%
3%
86%
127%
-328%
54%
108%
18%
 
EPS
7.16
4.85
5.55
4.73
4.60
2.48
-9.03
3.97
2.57
1.23
1.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
190
168
145
125
109
99
115
97
86
80
Share Capital
43
43
43
43
52
50
48
48
48
48
Total Reserves
146
125
101
81
57
35
67
50
38
33
Non-Current Liabilities
40
46
31
32
33
18
67
73
68
76
Secured Loans
0
0
0
0
0
1
1
3
5
7
Unsecured Loans
32
41
29
32
28
13
63
67
59
66
Long Term Provisions
7
6
5
5
4
4
4
4
3
3
Current Liabilities
140
135
136
136
122
158
117
93
96
81
Trade Payables
55
51
61
47
57
69
36
47
42
31
Other Current Liabilities
38
35
21
30
27
37
29
21
23
19
Short Term Borrowings
46
45
52
56
38
51
52
25
32
31
Short Term Provisions
1
3
1
3
0
1
0
0
0
0
Total Liabilities
370
349
312
293
264
275
299
263
250
237
Net Block
111
113
104
104
101
102
105
109
114
115
Gross Block
146
138
121
113
314
307
296
287
280
269
Accumulated Depreciation
35
26
17
8
213
205
191
178
166
154
Non Current Assets
148
142
118
114
110
105
139
141
144
148
Capital Work in Progress
30
24
10
6
3
1
20
20
19
19
Non Current Investment
0
0
0
0
0
0
1
1
1
1
Long Term Loans & Adv.
5
4
2
2
6
2
14
11
10
10
Other Non Current Assets
1
1
1
0
0
0
0
0
0
3
Current Assets
223
208
194
180
154
170
160
123
107
90
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
88
73
71
61
59
45
53
37
35
32
Sundry Debtors
93
87
65
73
57
81
56
51
39
34
Cash & Bank
5
4
6
7
5
4
5
4
10
1
Other Current Assets
37
6
4
2
34
40
46
31
23
22
Short Term Loans & Adv.
34
38
48
37
33
38
45
30
21
21
Net Current Assets
83
73
58
43
32
12
42
30
10
9
Total Assets
370
349
312
293
264
275
299
263
250
237

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
31
25
26
16
29
46
3
15
35
18
PBT
29
32
23
25
11
-39
17
11
5
4
Adjustment
22
13
14
25
20
77
26
23
19
22
Changes in Working Capital
-12
-16
-8
-33
-2
9
-40
-19
11
-8
Cash after chg. in Working capital
39
29
29
17
29
46
3
15
35
18
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-7
-4
-3
-1
0
0
0
0
0
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
-1
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-13
-25
-11
-18
-9
-10
-9
-9
-10
1
Net Fixed Assets
-5
-6
-5
36
-5
196
-9
-7
-11
-5
Net Investments
-1
-1
0
-1
-110
-39
0
0
0
4
Others
-7
-19
-5
-53
105
-166
-1
-2
1
2
Cash from Financing Activity
-18
-1
-15
2
-19
-37
7
-12
-19
-19
Net Cash Inflow / Outflow
0
0
0
0
0
0
0
-7
6
0
Opening Cash & Equivalents
0
0
1
1
1
1
1
7
1
1
Closing Cash & Equivalent
1
0
0
1
1
1
1
1
7
1

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
44
39
33
29
23
18
27
23
20
18
ROA
6%
7%
7%
7%
4%
-14%
6%
4%
2%
2%
ROE
12%
15%
15%
18%
12%
-43%
18%
13%
7%
7%
ROCE
14%
16%
14%
19%
13%
-12%
14%
12%
8%
7%
Fixed Asset Turnover
2.53
2.76
2.69
1.49
0.98
1.11
1.07
0.91
0.75
0.75
Receivable days
91
77
80
74
83
75
63
64
65
58
Inventory Days
82
74
76
68
62
54
52
51
60
53
Payable days
61
69
73
74
90
69
60
76
76
77
Cash Conversion Cycle
113
82
84
69
55
59
55
39
49
35
Total Debt/Equity
0.47
0.58
0.61
0.76
0.65
0.92
1.12
1.06
1.20
1.36
Interest Cover
4
5
4
3
2
-2
2
2
2
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.